Real-World Effectiveness of Insulin Glargine 300 U/ml in People with Type 2 Diabetes Previously Treated with Tirzepatide: The DELIVER-T Study.

Ritzel, Robert et al.·Diabetes therapy : research·2026·
RPEP-159992026RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Real-World Effectiveness of Insulin Glargine 300 U/ml in People with Type 2 Diabetes Previously Treated with Tirzepatide: The DELIVER-T Study.
Published In:
Diabetes therapy : research, treatment and education of diabetes and related disorders, 17(1), 133-147 (2026)
Database ID:
RPEP-15999

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-15999·https://rethinkpeptides.com/research/RPEP-15999

APA

Ritzel, Robert; Davies, Melanie J; Hao, Lichen; Ji, Linong; Mk, Lintu; Mabunay, Aileen; Mauricio, Didac; Bailey, Timothy. (2026). Real-World Effectiveness of Insulin Glargine 300 U/ml in People with Type 2 Diabetes Previously Treated with Tirzepatide: The DELIVER-T Study.. Diabetes therapy : research, treatment and education of diabetes and related disorders, 17(1), 133-147. https://doi.org/10.1007/s13300-025-01798-5

MLA

Ritzel, Robert, et al. "Real-World Effectiveness of Insulin Glargine 300 U/ml in People with Type 2 Diabetes Previously Treated with Tirzepatide: The DELIVER-T Study.." Diabetes therapy : research, 2026. https://doi.org/10.1007/s13300-025-01798-5

RethinkPeptides

RethinkPeptides Research Database. "Real-World Effectiveness of Insulin Glargine 300 U/ml in Peo..." RPEP-15999. Retrieved from https://rethinkpeptides.com/research/ritzel-2026-realworld-effectiveness-of-insulin

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.